Oral Anticoagulant Use in Atrial Fibrillation-Associated Ischemic Stroke: A Retrospective, Multicenter Survey in Northwestern China

Anticoagulation therapy has been recommended by major guidelines to reduce the risk of recurrent stroke in patients with atrial fibrillation-associated ischemic stroke (AFAIS). However, in real-world clinical practice, oral anticoagulants with either vitamin K antagonists or nonvitamin K antagonists are often underused for these patients. Here, we sought to investigate the current status of oral anticoagulant use in patients with AFAIS in northwestern China.

Source: Journal of Stroke and Cerebrovascular Diseases - September 15, 2016 Category: Neurology Authors: Jing Zhang, Xi-ai Yang, Yi Zhang, Jing-ya Wei, Feng Yang, Hua Gao, Wen-wen Jiao, Xiao-long Sun, Qiong Gao, Wen Jiang Source Type: research